| P2093 | author name string | A P Limaye | |
| | R A Zuckerman | |
| P2860 | cites work | HSV-2: in pursuit of a vaccine | Q22306291 |
| | A pooled analysis of the effect of condoms in preventing HSV-2 acquisition | Q24631935 |
| | Investigation of vesicular rashes for HSV and VZV by PCR | Q28109326 |
| | A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction | Q28112193 |
| | A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults | Q28254168 |
| | Incidence of Herpes Zoster, Before and After Varicella‐Vaccination–Associated Decreases in the Incidence of Varicella, 1992–2002 | Q28315859 |
| | Clinical correlates of herpes simplex virus viremia among hospitalized adults | Q33577281 |
| | Herpes Simplex Virus Hepatitis after Solid Organ Transplantation in Adults | Q34206932 |
| | Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. | Q34266505 |
| | Once-daily valacyclovir to reduce the risk of transmission of genital herpes | Q34287411 |
| | Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies | Q34291445 |
| | Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients | Q34293248 |
| | Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature | Q34559182 |
| | Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States | Q34559709 |
| | Detection of varicella-zoster virus DNA in air samples from hospital rooms | Q45777017 |
| | Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host | Q45793079 |
| | Antibody Responses to Varicella-Zoster Virus and the Role of Antibody in Host Defense | Q45801629 |
| | Transmission of infection with herpes simplex virus by renal transplantation | Q45835454 |
| | Detection of varicella-zoster virus DNA in the oropharynx and blood of patients with varicella | Q45877474 |
| | A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group | Q46117817 |
| | Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma | Q46382865 |
| | The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation | Q46512745 |
| | Contagiousness of varicella in vaccinated cases: a household contact study | Q46857001 |
| | Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. | Q53346269 |
| | Nonspecific immunoglobulin and granulocyte-macrophage colony-stimulating factor use in complicated varicella zoster: the first case report in a renal transplant recipient. | Q53735600 |
| | ASP2151 for the Treatment of Genital Herpes: A Randomized, Double-Blind, Placebo- and Valacyclovir-Controlled, Dose-Finding Study | Q57269673 |
| | Herpes Simplex Virus Infections in Solid Organ Transplant Recipients | Q57269717 |
| | Incidence and Clinical Characteristics of Herpes Zoster After Lung Transplantation | Q58075072 |
| | Doctor, Why Is My Herpes So Bad? The Search Continues | Q59282676 |
| | Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy | Q34579981 |
| | Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature | Q34586519 |
| | Herpes simplex and varicella zoster viruses: forgotten but not gone | Q34613055 |
| | Varicella zoster virus (VZV) in solid organ transplant recipients. | Q34615689 |
| | Varicella vaccination in pediatric kidney transplant candidates | Q34631309 |
| | Atypical generalized zoster with suspicious esophageal involvement and early relapse in an adult renal transplant recepient | Q34693399 |
| | Clinical practice. Herpes zoster | Q34768980 |
| | Varicella-Zoster Virus Reactivation without Rash | Q35229931 |
| | Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. | Q35551858 |
| | Varicella zoster virus: vaccination and implications in children with renal failure | Q35791770 |
| | In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs | Q35826062 |
| | Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study | Q35849423 |
| | Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients | Q35923346 |
| | Update on immunizations in solid organ transplant recipients: what clinicians need to know | Q37037796 |
| | Humoral and cellular immunity to varicella-zoster virus: an overview | Q37141183 |
| | Unusual presentation of Ramsay Hunt syndrome in renal transplant patients: case report and literature review | Q37322590 |
| | Aciclovir and Varicella-zoster-immunoglobulin in solid-organ transplant recipients | Q37809492 |
| | Controlled clinical trial of intravenous acyclovir in heart-transplant patients with mucocutaneous herpes simplex infections | Q39567475 |
| | Genital herpes simplex virus infections: clinical manifestations, course, and complications | Q40150591 |
| | Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. | Q40486515 |
| | Infectious ocular complications in orthotopic liver transplant patients | Q41508709 |
| | A comparative study of herpes simplex infections in renal transplant and leukemic patients | Q42058885 |
| | Prophylaxis or modification of varicella by oral acyclovir after household exposure | Q42129849 |
| | Successful treatment of an aciclovir-resistant herpes simplex type 2 infection with cidofovir in an AIDS patient | Q43513739 |
| | Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons | Q43704029 |
| | Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials | Q43861427 |
| | Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation | Q44157444 |
| | Acyclovir prophylaxis of varicella in children with renal disease receiving steroids | Q44184518 |
| | Transferred herpes simplex virus immunity after stem-cell transplantation: clinical implications | Q44323700 |
| | Disseminated varicella infection in adult renal allograft recipients: role of mycophenolate mofetil | Q44577597 |
| | Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. | Q44695054 |
| | Natural history of genital herpes simplex virus type 1 infection | Q44950861 |
| | Disseminated herpes simplex type-2 (HSV-2) infection after solid-organ transplantation | Q44972744 |
| | Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture | Q45162165 |
| | Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir | Q45216102 |
| | Transmission of varicella zoster virus from individuals with herpes zoster or varicella in school and day care settings. | Q45358735 |
| | Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis | Q45398628 |
| | Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease | Q45402938 |
| | National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. | Q45533092 |
| | Are false negative direct immnufluorescence assays caused by varicella zoster virus gE mutant strains? | Q45621324 |
| | Detection of aerosolized varicella-zoster virus DNA in patients with localized herpes zoster | Q45670518 |
| | Detection of varicella-zoster virus DNA in throat swabs of patients with herpes zoster and on air purifier filters | Q45733672 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 55-66; quiz 66 | |
| P577 | publication date | 2013-02-01 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Varicella zoster virus (VZV) and herpes simplex virus (HSV) in solid organ transplant patients | |
| P478 | volume | 13 Suppl 3 | |